Decades of research push cytomegalovirus vaccine closer to reality

Researchers review decades of progress in human cytomegalovirus (HCMV) vaccine development, emphasizing challenges, innovative platforms, and the critical need for effective prevention strategies.

Among pharma CEOs, the IRA now and the IRA later get very different reactions

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

July 27, 2024

An update on the health benefits of olive oil

Researchers summarize recent evidence on the clinical impact of olive oil on human health.

August 29, 2023

Change in Evolva Holding SA’s shareholder structure – Biotech Investments

Evolva Holding SA / Key word(s): DisposalChange in Evolva Holding SA’s shareholder structure 30-Dec-2024 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art.

December 31, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.